3042-4954 Screening compound: 3,4-diphenyl-5-[3-(trifluoromethyl)phenyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one

3042-4954 Screening compound: 3,4-diphenyl-5-[3-(trifluoromethyl)phenyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one
3042-4954 Screening compound: 3,4-diphenyl-5-[3-(trifluoromethyl)phenyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one alternative view

Chemical Structure Depiction of ChemDiv screening compound 3042-4954
3,4-diphenyl-5-[3-(trifluoromethyl)phenyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3042-4954

Molecular Formula

C24H16F3N3O (C24 H16 F3 N3 O)

Compound Name

3,4-diphenyl-5-[3-(trifluoromethyl)phenyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one

IUPAC name

34-diphenyl-5-[3-(trifluoromethyl)phenyl]-1H4H5H6H-pyrrolo[34-c]pyrazol-6-one

SMILES

O=C(c1c(C2c3ccccc3)c(-c3ccccc3)n[nH]1)N2c1cccc(C(F)(F)F)c1

InChI

InChI=1S/C24H16F3N3O/c25-24(26,27)17-12-7-13-18(14-17)30-22(16-10-5-2-6-11-16)19-20(15-8-3-1-4-9-15)28-29-21(19)23(30)31/h1-14,22H,(H,28,29)/t22-/m1/s1

InChI Key

QGVMZODZFSNDHL-JOCHJYFZSA-N

MDL Number (MFCD)

MFCD01815704

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

419.41

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.459

Distribution Coefficient, logD

5.458

Water Solubility, LogSw

-6.00

Polar Surface Area

39.527

Acid Dissociation Constant (pKa)

11.45

Base Dissociation Constant (pKb)

-3.77

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

8.30

3042-4954 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anti-infective Library (19449 compounds)

Antiviral Library (67538 compounds)

CNS targets activity set (6557 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with 3042-4954 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3042-4954?
Check Price and Availability of 3042-4954, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3042-4954 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3042-4954
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3042-4954
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3042-4954 available by request